1. Home
  2. SWIN vs COEP Comparison

SWIN vs COEP Comparison

Compare SWIN & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWIN
  • COEP
  • Stock Information
  • Founded
  • SWIN 2017
  • COEP 2017
  • Country
  • SWIN Hong Kong
  • COEP United States
  • Employees
  • SWIN N/A
  • COEP N/A
  • Industry
  • SWIN
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SWIN
  • COEP Health Care
  • Exchange
  • SWIN Nasdaq
  • COEP Nasdaq
  • Market Cap
  • SWIN 214.1M
  • COEP 27.4M
  • IPO Year
  • SWIN 2023
  • COEP N/A
  • Fundamental
  • Price
  • SWIN $3.95
  • COEP $10.95
  • Analyst Decision
  • SWIN
  • COEP
  • Analyst Count
  • SWIN 0
  • COEP 0
  • Target Price
  • SWIN N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • SWIN 216.6K
  • COEP 56.9K
  • Earning Date
  • SWIN 08-21-2025
  • COEP 08-15-2025
  • Dividend Yield
  • SWIN N/A
  • COEP N/A
  • EPS Growth
  • SWIN N/A
  • COEP N/A
  • EPS
  • SWIN N/A
  • COEP N/A
  • Revenue
  • SWIN $3,316,000.00
  • COEP $62,874.00
  • Revenue This Year
  • SWIN $29.79
  • COEP N/A
  • Revenue Next Year
  • SWIN $54.60
  • COEP N/A
  • P/E Ratio
  • SWIN N/A
  • COEP N/A
  • Revenue Growth
  • SWIN N/A
  • COEP N/A
  • 52 Week Low
  • SWIN $1.16
  • COEP $2.31
  • 52 Week High
  • SWIN $4.40
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • SWIN 59.60
  • COEP 59.53
  • Support Level
  • SWIN $3.29
  • COEP $11.30
  • Resistance Level
  • SWIN $3.99
  • COEP $12.71
  • Average True Range (ATR)
  • SWIN 0.39
  • COEP 0.89
  • MACD
  • SWIN -0.04
  • COEP 0.18
  • Stochastic Oscillator
  • SWIN 80.93
  • COEP 54.39

About SWIN Solowin Holdings

Solowin Holdings Ltd is an investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secure one-stop electronic platform. It is engaged in providing securities-related services, investment advisory services, and asset management services to customers. The operations were organized into four reportable segments: Corporate Finance Services, Wealth Management Services, Asset Management Services and Virtual Assets. It derives maximum revenue from Wealth Management Services.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: